Abstract
Lymphocytes of melanoma patients can be restimulated in vitro with autologous tumor cells to generate antitumor cytolytic T lymphocytes (CTL). Previous reports have indicated that, when such CTL are obtained from HLA-A2 melanoma patients, they often display broad reactivity on A2 melanoma cell lines. Such antitumor CTL clones, which appeared to recognize the same antigen, were isolated from two patients. We report here the cloning of a cDNA that directs the expression of the antigen recognized by these CTL. This cDNA corresponds to the transcript of the tyrosinase gene. The gene was found to be active in all tested melanoma samples and in most melanoma cell lines. Among normal cells, only melanocytes appear to express the gene. The tyrosinase antigen presented by HLA-A2 may therefore constitute a useful target for specific immunotherapy of melanoma. But possible adverse effects of antityrosinase immunization, such as the destruction of normal melanocytes and its consequences, will have to be examined before clinical pilot studies can be undertaken.
MeSH Terms
Animals
Antigens, Neoplasm/genetics,immunology
Cell Line
Clone Cells
Cloning, Molecular
DNA
Female
HLA-A2 Antigen/immunology
Humans
Melanoma/immunology,pathology
Monophenol Monooxygenase/genetics,immunology
Skin Neoplasms/immunology,pathology
T-Lymphocytes, Cytotoxic/immunology
Tumor Cells, Cultured
Chemicals
Antigens, Neoplasm
HLA-A2 Antigen
DNA
Monophenol Monooxygenase
Authors & Affiliations
8 authors, click to expand affiliations / ORCID
Brichard V
Ludwig Institute for Cancer Research, Brussels Branch, Belgium.
Van Pel A
Wölfel T
Wölfel C
De Plaen E
Lethé B
Coulie P
Boon T
References (25)
25 references, click to expand
-
Immunogenic variants obtained by mutagenesis of mouse mastocytoma P815. II. T lymphocyte-mediated cytolysis.
J Exp Med. 1980 Nov 1;152(5):1184-93
PMID: 6776227
-
Induction of pigmentation in mouse fibroblasts by expression of human tyrosinase cDNA.
J Exp Med. 1989 Jun 1;169(6):2029-42
PMID: 2499655
-
Human melanoma antigen AH is an autoantigenic ganglioside related to GD2.
J Exp Med. 1982 Dec 1;156(6):1884-9
PMID: 7175442
-
Clonal analysis of cytotoxic T cell response against human melanoma.
J Exp Med. 1983 Jul 1;158(1):240-5
PMID: 6602860
-
A pigmentation-associated, differentiation antigen of human melanoma defined by a precipitating antibody in human serum.
Int J Cancer. 1983 Dec 15;32(6):717-21
PMID: 6197381
-
Lysis of human melanoma cells by autologous cytolytic T cell clones. Identification of human histocompatibility leukocyte antigen A2 as a restriction element for three different antigens.
J Exp Med. 1989 Sep 1;170(3):797-810
PMID: 2788708
-
Presence on a human melanoma of multiple antigens recognized by autologous CTL.
Int J Cancer. 1989 Oct 15;44(4):634-40
PMID: 2529220
-
Structure of the gene of tum- transplantation antigen P35B: presence of a point mutation in the antigenic allele.
EMBO J. 1990 Apr;9(4):1041-50
PMID: 2108859
-
The melanoma antigen gp75 is the human homologue of the mouse b (brown) locus gene product.
J Exp Med. 1990 Apr 1;171(4):1375-80
PMID: 2324688
-
The gene coding for a major tumor rejection antigen of tumor P815 is identical to the normal gene of syngeneic DBA/2 mice.
J Exp Med. 1991 Jun 1;173(6):1373-84
PMID: 1903428
-
A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma.
Science. 1991 Dec 13;254(5038):1643-7
PMID: 1840703
-
Transfection and expression of a gene coding for a human melanoma antigen recognized by autologous cytolytic T lymphocytes.
Immunogenetics. 1992;35(3):145-52
PMID: 1537606
-
A nonapeptide encoded by human gene MAGE-1 is recognized on HLA-A1 by cytolytic T lymphocytes directed against tumor antigen MZ2-E.
J Exp Med. 1992 Nov 1;176(5):1453-7
PMID: 1402688
-
Human gene MAGE-1, which codes for a tumor-rejection antigen, is expressed by some breast tumors.
Int J Cancer. 1992 Nov 11;52(5):839-41
PMID: 1428237
-
T-cell-mediated cytotoxicity against autologous malignant melanoma: analysis with interleukin 2-dependent T-cell cultures.
Proc Natl Acad Sci U S A. 1984 Jun;81(11):3511-5
PMID: 6610177
-
Cellular immune response to human sarcomas: cytotoxic T cell clones reactive with autologous sarcomas. I. Development, phenotype, and specificity.
J Immunol. 1986 Nov 1;137(9):3042-8
PMID: 3093588
-
Production of stable cytolytic T-cell clones directed against autologous human melanoma.
Int J Cancer. 1987 Mar 15;39(3):390-6
PMID: 3493226
-
Molecular cloning of the CD2 antigen, the T-cell erythrocyte receptor, by a rapid immunoselection procedure.
Proc Natl Acad Sci U S A. 1987 May;84(10):3365-9
PMID: 2437578
-
Prognostic significance of hypopigmentation in malignant melanoma.
Arch Dermatol. 1987 Aug;123(8):1053-5
PMID: 3631983
-
Isolation and sequence of a cDNA clone for human tyrosinase that maps at the mouse c-albino locus.
Proc Natl Acad Sci U S A. 1987 Nov;84(21):7473-7
PMID: 2823263
-
Isolation and characterization of the human tyrosine hydroxylase gene: identification of 5' alternative splice sites responsible for multiple mRNAs.
Biochemistry. 1987 Nov 3;26(22):6910-4
PMID: 2892528
-
Immunogenic (tum-) variants of mouse tumor P815: cloning of the gene of tum- antigen P91A and identification of the tum- mutation.
Proc Natl Acad Sci U S A. 1988 Apr;85(7):2274-8
PMID: 3127830
-
Cytolytic T-cell clones against an autologous human melanoma: specificity study and definition of three antigens by immunoselection.
Proc Natl Acad Sci U S A. 1989 Apr;86(8):2804-8
PMID: 2784858
-
The role of HLA class I antigens in recognition of melanoma cells by tumor-specific cytotoxic T lymphocytes. Evidence for shared tumor antigens.
J Immunol. 1989 May 1;142(9):3329-35
PMID: 2785141
-
Specificity of auto-tumor cytotoxicity exerted by fresh, activated and propagated human T lymphocytes.
Int J Cancer. 1982 May 15;29(5):547-53
PMID: 6178704